Literature DB >> 6363928

Vasodilator therapy of heart failure. Has the promissory note been paid?

E Braunwald, W S Colucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6363928     DOI： 10.1056/NEJM198402163100711

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Prazosin for refractory cardiac failure in children.

Authors:  H Netz; K J Hagel; G Röhner; H W Rautenburg
Journal:  Pediatr Cardiol       Date:  1984       Impact factor: 1.655

Review 2.  Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.

Authors:  I Crozier; H Ikram
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

Review 3.  The use of angiotensin-converting enzyme inhibitors in congestive heart failure.

Authors:  J L Rouleau; C Juneau; J de Champlain
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

Review 4.  Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.

Authors:  J P Mulrow; M H Crawford
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.